Clinical Trial

Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes

Study acronym: GLAM
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated August 2024 completion). Its status may not reflect the trial's current state.
Summary
Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people with type 2 diabetes facilitates time in glycaemic range in the 6 months after an acute myocardial infarction. As an exploratory outcome it will investigate whether time in glycaemic range is associated with changes in mortality and major adverse cardiac events in the 6 months after acute myocardial infarct.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05431296
Lead Sponsor Imperial College London
Conditions Type 2 Diabetes, Acute Myocardial Infarction, Acute Myocardial Infarction With ST Elevation, Diabetes Complications
Enrollment 160 participants
Start Date 2023-02-07
Primary Completion 2024-08 (estimated)
Study Completion 2025-02 (estimated)
Updated on ClinicalTrials.gov 2024-07-03